Market by Product, Application, Industry Verticals, and Geography | Forecast 2021-2028
CRISPR,
Clustered Regularly Interspaced Short Palindromic Repeats, is considered the
hallmark of bacterial defense systems that form the basis of CRISPR-Cas9 genome
editing technology. CRISPR-Cas (CRISPR-associated proteins) is a revolutionary
tool that helps biomedical research to grow. As per Triton Market Research, the
global CRISPR market was valued at $1284.07 million in 2020 and is expected to
reach $4521.76 million by 2028, growing at a CAGR of 20.38% during the
forecasted period 2021 to 2028.
Report scope can be customized per your requirements. Request For Customization
Triton’s
report on CRISPR provides an in-depth insight into the market. The detailed
analysis of the market includes key insights, Porter’s five forces analysis,
market attractiveness index, vendor scorecard, legal & regulatory
framework, patent outlook, funding outlook, key strategies, key impact
analysis, and impact of COVID-19 on the market.
The
market is driven by several factors, such as the growing lifestyle-oriented diseases,
the high prevalence of genetic disorders, and a rise in awareness about gene
therapeutics. The advancements in gene-based therapy in the agricultural sector
are increasing due to CRISPR-Cas’s ability to precisely manipulate the plant
genomes on a global level. Furthermore, CRISPR-Cas aims to facilitate the
upbringing of high-quality crops, which further uses enhancements in y-aminobutyric acid and carotenoid, along with a reduction in high oleic acid
contents and phytic acid.
Further,
the increase in the use of prospective applications of CRISPR technology is
anticipated to positively impact this market’s growth, creating opportunities
for the CRISPR market. For example, in June 2017, the scientists at Synthetic
Genomics and ExxonMobil created an oil-rich strain of algae with the help of
CRISPR tools that could be turned into fuel. Besides, some researchers are
trying to use CRISPR technology to reverse the extinction of some animals and
plants.
Conversely, the market has been negatively affected due to the growing ethical issues relating to technology use. This moral debate arises after the modifications on any living organism’s genes through the use of CRISPR. Additionally, more concerns arise when the same technique is used to modify insects, animals, plants, and even micro-organisms. Along with this, factors such as likely misuse of gene-editing tools and the absence of healthcare budgets in developing countries are restricting the growth of the CRISPR market.
Key geographies covered in the global CRISPR
market are:
• North America: United States and
Canada
• Europe: United Kingdom, France,
Germany, Spain, Italy, Russia, and Rest of Europe
• Asia-Pacific: China, Japan, India,
South Korea, ASEAN Countries, Australia & New Zealand, and Rest of
Asia-Pacific
• Latin America: Brazil, Mexico, and
Rest of Latin America
• Middle East and Africa: Saudi Arabia,
Turkey, United Arab Emirates, South Africa, and Rest of Middle East &
Africa
The segmentation analysis of the CRISPR market
includes:
• Market by Product:
o Plasmids
o Vectors
o Proteins
o Designing
Tools
o gRNA
o Control
Kits
o Library
o Other
Products
• Market by Application:
o Genome
Editing/Genetic Engineering
o gRNA
Database/Gene Library
o CRISPR
Plasmid
o Human
Stem Cells
o Cell
Line Engineering
• Market by Industry Verticals:
o Therapeutics
and Drug Discovery
o Biological
Research
o Agricultural
Biotech
o Industrial
Biotech
The eminent players in the CRISPR market are
Horizon Discovery Group, Caribou Biosciences Inc, Intellia Therapeutics,
Novartis International AG, OriGene Technologies Inc, Editas Medicine, Addgene,
Lonza Group Ltd, Precision Biosciences, Integrated DNA Technologies, Cellectis
Bioresearch SAS, New England Biolabs, CRISPR Therapeutics AG, Synthego
Corporation, and Genscript.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. GLOBAL
CRISPR MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON CRISPR MARKET
2.2. KEY
INSIGHTS
2.2.1. INDUSTRIAL
BIOTECH IS THE FASTEST GROWING INDUSTRY VERTICAL
2.2.2. REWRITING
OF GENETIC DISORDERS THROUGH GENOME SURGERY
2.2.3. INCREASING
USAGE OF PROSPECTIVE APPLICATIONS OF CRISPR TECHNOLOGY
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. LEGAL
& REGULATORY OUTLOOK
2.7. PATENT
OUTLOOK
2.8. FUNDING
OUTLOOK
2.9. KEY
IMPACT ANALYSIS
2.9.1. COST
2.9.2. ACCURACY
2.9.3. EASY
TO USE
2.10. KEY
MARKET STRATEGIES
2.10.1. ACQUISITIONS
2.10.2. PRODUCT
LAUNCHES
2.10.3. CONTRACTS
& PARTNERSHIPS
2.10.4. BUSINESS
EXPANSIONS & DIVESTITURES
2.11. MARKET
DRIVERS
2.11.1. GROWING
LIFESTYLE-ORIENTED DISEASES
2.11.2. SURGING
PREVALENCE OF GENETIC DISEASES
2.12. MARKET
CHALLENGES
2.12.1. GROWING
ETHICAL ISSUES REGARDING TECHNOLOGY USE
2.12.2. LIKELY
MISUSE OF GENE-EDITING TOOL
2.12.3. ABSENCE
OF HEALTHCARE BUDGETS IN DEVELOPING COUNTRIES
2.13. MARKET
OPPORTUNITIES
2.13.1. ADVANCEMENTS
IN GENE-BASED THERAPY IN THE AGRICULTURAL SECTOR
2.13.2. INCREASED
NEED FOR CLINICAL TRIALS
2.13.3. RISE
IN AWARENESS ABOUT GENE THERAPEUTICS
3. GLOBAL
CRISPR MARKET OUTLOOK - BY PRODUCT
3.1. PLASMIDS
3.2. VECTORS
3.3. PROTEINS
3.4. DESIGNING
TOOLS
3.5. GRNA
3.6. CONTROL
KITS
3.7. LIBRARY
3.8. OTHER
PRODUCTS
4. GLOBAL
CRISPR MARKET OUTLOOK - BY APPLICATION
4.1. GENOME
EDITING/GENETIC ENGINEERING
4.2. CRISPR
PLASMID
4.3. HUMAN
STEM CELLS
4.4. GRNA
DATABASE/GENE LIBRARY
4.5. CELL
LINE ENGINEERING
5. GLOBAL
CRISPR MARKET OUTLOOK - BY INDUSTRY VERTICALS
5.1. THERAPEUTICS
AND DRUG DISCOVERY
5.2. BIOLOGICAL
RESEARCH
5.3. AGRICULTURAL
BIOTECH
5.4. INDUSTRIAL
BIOTECH
6. GLOBAL
CRISPR MARKET – REGIONAL OUTLOOK
6.1. NORTH
AMERICA
6.1.1. MARKET
BY PRODUCT
6.1.2. MARKET
BY APPLICATION
6.1.3. MARKET
BY INDUSTRY VERTICALS
6.1.4. COUNTRY
ANALYSIS
6.1.4.1. UNITED
STATES
6.1.4.2. CANADA
6.2. EUROPE
6.2.1. MARKET
BY PRODUCT
6.2.2. MARKET
BY APPLICATION
6.2.3. MARKET
BY INDUSTRY VERTICALS
6.2.4. COUNTRY
ANALYSIS
6.2.4.1. UNITED
KINGDOM
6.2.4.2. GERMANY
6.2.4.3. FRANCE
6.2.4.4. SPAIN
6.2.4.5. ITALY
6.2.4.6. RUSSIA
6.2.4.7. REST
OF EUROPE
6.3. ASIA-PACIFIC
6.3.1. MARKET
BY PRODUCT
6.3.2. MARKET
BY APPLICATION
6.3.3. MARKET
BY INDUSTRY VERTICALS
6.3.4. COUNTRY
ANALYSIS
6.3.4.1. CHINA
6.3.4.2. JAPAN
6.3.4.3. INDIA
6.3.4.4. SOUTH
KOREA
6.3.4.5. ASEAN
COUNTRIES
6.3.4.6. AUSTRALIA
& NEW ZEALAND
6.3.4.7. REST
OF ASIA-PACIFIC
6.4. LATIN
AMERICA
6.4.1. MARKET
BY PRODUCT
6.4.2. MARKET
BY APPLICATION
6.4.3. MARKET
BY INDUSTRY VERTICALS
6.4.4. COUNTRY
ANALYSIS
6.4.4.1. BRAZIL
6.4.4.2. MEXICO
6.4.4.3. REST
OF LATIN AMERICA
6.5. MIDDLE
EAST AND AFRICA
6.5.1. MARKET
BY PRODUCT
6.5.2. MARKET
BY APPLICATION
6.5.3. MARKET
BY INDUSTRY VERTICALS
6.5.4. COUNTRY
ANALYSIS
6.5.4.1. UNITED
ARAB EMIRATES
6.5.4.2. SAUDI
ARABIA
6.5.4.3. TURKEY
6.5.4.4. SOUTH
AFRICA
6.5.4.5. REST
OF MIDDLE EAST & AFRICA
7. COMPETITIVE
LANDSCAPE
7.1. ADDGENE
7.2. CARIBOU
BIOSCIENCES INC
7.3. CELLECTIS
BIORESEARCH SAS
7.4. CRISPR
THERAPEUTICS AG
7.5. EDITAS
MEDICINE
7.6. GENSCRIPT
7.7. HORIZON
DISCOVERY GROUP
7.8. INTEGRATED
DNA TECHNOLOGIES
7.9. INTELLIA
THERAPEUTICS
7.10. LONZA
GROUP LTD
7.11. NEW
ENGLAND BIOLABS
7.12. NOVARTIS
INTERNATIONAL AG
7.13. ORIGENE
TECHNOLOGIES INC
7.14. PRECISION
BIOSCIENCES
7.15. SYNTHEGO
CORPORATION
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: GLOBAL CRISPR MARKET,
BY GEOGRAPHY, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: REGULATORY FRAMEWORK
TABLE 4: FUNDING OUTLOOK OF
PUBLIC COMPANIES
TABLE 5: FUNDING OUTLOOK OF
PRIVATE COMPANIES
TABLE 6: FUNDING OUTLOOK OF
GOVERNMENT ORGANIZATIONS
TABLE 7: GLOBAL CRISPR MARKET,
BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 8: GLOBAL CRISPR MARKET,
BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 9: GLOBAL CRISPR MARKET,
BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 10: GLOBAL CRISPR
MARKET, BY GEOGRAPHY, 2021-2028 (IN $ MILLION)
TABLE 11: NORTH AMERICA CRISPR
MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 12: NORTH AMERICA CRISPR
MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 13: NORTH AMERICA CRISPR
MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 14: NORTH AMERICA CRISPR
MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 15: EUROPE CRISPR
MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 16: EUROPE CRISPR
MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 17: EUROPE CRISPR
MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 18: EUROPE CRISPR
MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 19: ASIA-PACIFIC CRISPR
MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 20: ASIA-PACIFIC CRISPR
MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 21: ASIA-PACIFIC CRISPR
MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 22: ASIA-PACIFIC CRISPR
MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 23: LATIN AMERICA CRISPR
MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 24: LATIN AMERICA CRISPR
MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 25: LATIN AMERICA CRISPR
MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 26: LATIN AMERICA CRISPR
MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 27: MIDDLE EAST AND
AFRICA CRISPR MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 28: MIDDLE EAST AND
AFRICA CRISPR MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 29: MIDDLE EAST AND
AFRICA CRISPR MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 30: MIDDLE EAST
AND AFRICA CRISPR MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
FIGURE 1: MARKET
ATTRACTIVENESS INDEX
FIGURE 2: FUNDING SCENARIO
SHARE, BY TYPE OF COMPANIES/ORGANIZATION
FIGURE 3: KEY IMPACT ANALYSIS
FIGURE 4: GLOBAL CRISPR
MARKET, BY PRODUCT, 2020 & 2028 (IN %)
FIGURE 5: GLOBAL CRISPR
MARKET, BY PLASMIDS, 2021-2028 (IN $ MILLION)
FIGURE 6: GLOBAL CRISPR
MARKET, BY VECTORS, 2021-2028 (IN $ MILLION)
FIGURE 7: GLOBAL CRISPR
MARKET, BY PROTEINS, 2021-2028 (IN $ MILLION)
FIGURE 8: GLOBAL CRISPR
MARKET, BY DESIGNING TOOLS, 2021-2028 (IN $ MILLION)
FIGURE 9: GLOBAL CRISPR
MARKET, BY GRNA, 2021-2028 (IN $ MILLION)
FIGURE 10: GLOBAL CRISPR
MARKET, BY CONTROL KITS, 2021-2028 (IN $ MILLION)
FIGURE 11: GLOBAL CRISPR
MARKET, BY LIBRARY, 2021-2028 (IN $ MILLION)
FIGURE 12: GLOBAL CRISPR
MARKET, BY OTHER PRODUCTS, 2021-2028 (IN $ MILLION)
FIGURE 13: GLOBAL CRISPR
MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE 14: GLOBAL CRISPR
MARKET, BY GENOME EDITING/GENETIC ENGINEERING, 2021-2028 (IN $ MILLION)
FIGURE 15: GLOBAL CRISPR
MARKET, BY CRISPR PLASMID, 2021-2028 (IN $ MILLION)
FIGURE 16: GLOBAL CRISPR
MARKET, BY HUMAN STEM CELLS, 2021-2028 (IN $ MILLION)
FIGURE 17: GLOBAL CRISPR
MARKET, BY GRNA DATABASE/GENE LIBRARY, 2021-2028 (IN $ MILLION)
FIGURE 18: GLOBAL CRISPR
MARKET, BY CELL LINE ENGINEERING, 2021-2028 (IN $ MILLION)
FIGURE 19: GLOBAL CRISPR
MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)
FIGURE 20: GLOBAL CRISPR
MARKET, BY THERAPEUTICS AND DRUG DISCOVERY, 2021-2028 (IN $ MILLION)
FIGURE 21: GLOBAL CRISPR
MARKET, BY BIOLOGICAL RESEARCH, 2021-2028 (IN $ MILLION)
FIGURE 22: GLOBAL CRISPR
MARKET, BY AGRICULTURAL BIOTECH, 2021-2028 (IN $ MILLION)
FIGURE 23: GLOBAL CRISPR
MARKET, BY INDUSTRIAL BIOTECH, 2021-2028 (IN $ MILLION)
FIGURE 24: GLOBAL CRISPR
MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 25: UNITED STATES
CRISPR MARKET 2021-2028 (IN $ MILLION)
FIGURE 26: CANADA CRISPR
MARKET 2021-2028 (IN $ MILLION)
FIGURE 27: UNITED KINGDOM
CRISPR MARKET 2021-2028 (IN $ MILLION)
FIGURE 28: GERMANY CRISPR
MARKET 2021-2028 (IN $ MILLION)
FIGURE 29: FRANCE CRISPR
MARKET 2021-2028 (IN $ MILLION)
FIGURE 30: SPAIN CRISPR MARKET
2021-2028 (IN $ MILLION)
FIGURE 31: ITALY CRISPR MARKET
2021-2028 (IN $ MILLION)
FIGURE 32: RUSSIA CRISPR
MARKET 2021-2028 (IN $ MILLION)
FIGURE 33: REST OF EUROPE
CRISPR MARKET 2021-2028 (IN $ MILLION)
FIGURE 34: CHINA CRISPR MARKET
2021-2028 (IN $ MILLION)
FIGURE 35: JAPAN CRISPR MARKET
2021-2028 (IN $ MILLION)
FIGURE 36: INDIA CRISPR MARKET
2021-2028 (IN $ MILLION)
FIGURE 37: SOUTH KOREA CRISPR
MARKET 2021-2028 (IN $ MILLION)
FIGURE 38: ASEAN COUNTRIES
CRISPR MARKET 2021-2028 (IN $ MILLION)
FIGURE 39: AUSTRALIA & NEW
ZEALAND CRISPR MARKET 2021-2028 (IN $ MILLION)
FIGURE 40: REST OF ASIA-PACIFIC
CRISPR MARKET 2021-2028 (IN $ MILLION)
FIGURE 41: BRAZIL CRISPR
MARKET 2021-2028 (IN $ MILLION)
FIGURE 42: MEXICO CRISPR
MARKET 2021-2028 (IN $ MILLION)
FIGURE 43: REST OF LATIN
AMERICA CRISPR MARKET 2021-2028 (IN $ MILLION)
FIGURE 44: UNITED ARAB
EMIRATES CRISPR MARKET 2021-2028 (IN $ MILLION)
FIGURE 45: SAUDI ARABIA CRISPR
MARKET 2021-2028 (IN $ MILLION)
FIGURE 46: TURKEY CRISPR
MARKET 2021-2028 (IN $ MILLION)
FIGURE 47: SOUTH AFRICA CRISPR
MARKET 2021-2028 (IN $ MILLION)
FIGURE 48: REST OF MIDDLE EAST
& AFRICA CRISPR MARKET 2021-2028 (IN $ MILLION)